Picture of Daihan Scientific Co logo

131220 Daihan Scientific Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareBalancedMicro CapContrarian

Annual cashflow statement for Daihan Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line5,0156,2425,2223,9264,779
Depreciation
Amortisation
Non-Cash Items1,0591,1721,325742793
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3,493-4,591-3,592-2,521-1,910
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,1324,5124,7933,9875,444
Capital Expenditures-3,225-3,077-646-494-317
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1,125-1,302-2,081-743-2,911
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-4,350-4,380-2,727-1,237-3,228
Financing Cash Flow Items35939589-1.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities908-720-1,380-3,082-2,543
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash692-601642-326-352